Gianmarco Mola
Via Luigi Borsari 46
Ferrara, 44121, Italy
Ferrara, 44121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia.
Journal: Antioxidants (Basel, Switzerland)
Published: July 03, 2026
Myeloperoxidase (MPO) Enzymatic Activity, but Not Its Protein Concentration, Is Associated with the Risk of Type 2 Diabetes in Females, Regardless of Obesity Status.
Journal: Antioxidants (Basel, Switzerland)
Published: December 04, 2025
Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women.
Journal: Antioxidants (Basel, Switzerland)
Published: August 22, 2025
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease.
Journal: Current pharmaceutical design
Published: April 29, 2025
PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles.
Journal: Antioxidants (Basel, Switzerland)
Published: September 10, 2024
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer's Disease.
Journal: Current pharmaceutical design
Published: July 17, 2024
Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Dementia: A Pilot Study.
Journal: International journal of molecular sciences
Published: July 05, 2024
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.
Journal: Neurochemistry international
Published: October 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026